Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 8;13(5):e70501.
doi: 10.1002/ccr3.70501. eCollection 2025 May.

Successful and Sustained Treatment of Cutaneous Tumoral Lesions in Brooke-Spiegler Syndrome (BSS) Using Ablative CO2 Laser: A Case Series and Literature Review

Affiliations

Successful and Sustained Treatment of Cutaneous Tumoral Lesions in Brooke-Spiegler Syndrome (BSS) Using Ablative CO2 Laser: A Case Series and Literature Review

Nikoo Mozafari et al. Clin Case Rep. .

Abstract

Continuous-wave CO2 laser therapy is an effective and safe treatment for trichoepitheliomas in Brooke-Spiegler syndrome, improving lesion color, texture, and overall appearance. This non-invasive approach offers high patient satisfaction and demonstrated no recurrence during a 2-year follow-up, making it a promising alternative to surgical excision.

Keywords: Brooke–Spiegler syndrome; CYLD; adnexal tumors; dermatology; trichoepitheliomas.

PubMed Disclaimer

Conflict of interest statement

Transparency declaration: The authors affirm that the manuscript is honest, accurate, and transparent. No important aspect of the study has been omitted.The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Histopathological views of trichoepitheliomas in Case 1 (A–C), Case 2 (D–F), and Case 3 (G, H).
FIGURE 2
FIGURE 2
Photographs of trichoepithelioma lesions before and after treatment with two sessions of continuous‐wave CO2 laser therapy in Case 1 (A), Case 2 (B), and Case 3 (C).

Similar articles

References

    1. Kazakov D. V., “Brooke‐Spiegler Syndrome and Phenotypic Variants: An Update,” Head and Neck Pathology 10, no. 2 (2016): 125–130. - PMC - PubMed
    1. Kazakov D. V., Soukup R., Mukensnabl P., Boudova L., and Michal M., “Brooke‐Spiegler Syndrome: Report of a Case With Combined Lesions Containing Cylindromatous, Spiradenomatous, Trichoblastomatous, and Sebaceous Differentiation,” American Journal of Dermatopathology 27, no. 1 (2005): 27–33. - PubMed
    1. Mohiuddin W., Laun J., and Cruse W., “Brooke‐Spiegler Syndrome,” Eplasty 18 (2018): ic14. - PMC - PubMed
    1. Blake P. W. and Toro J. R., “Update of Cylindromatosis Gene (CYLD) Mutations in Brooke‐Spiegler Syndrome: Novel Insights Into the Role of Deubiquitination in Cell Signaling,” Human Mutation 30, no. 7 (2009): 1025–1036. - PMC - PubMed
    1. Farshad F., Behrangi E., Jafarzadeh A., et al., “Assessing the Concordance of Clinical and Pathological Diagnoses in Basal Cell Carcinoma Among the Iranian Population: A Cross‐Sectional Analysis of 229 Cases,” Cancer Research 7, no. 10 (2024): e70040, 10.1002/cnr2.70040. - DOI - PMC - PubMed

LinkOut - more resources